Keytruda Is King, But Merck Faces Questions About Business Development

 
• By Mary Jo Laffler
  
chess
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer